Abstract
Eleven patients with chronic ventricular arrhythmias took part in a study of N-acetylprocainamide (NAPA), the major metabolite of procainamide, in order to characterize further NAPA's clinical pharmacology and antiarrhythmic action. The frequency of ventricular arrhythmia on 24 hour ambulatory electrocardiographic recordings was comparable on recordings obtained in a prestudy screening, during treatment with placebo before administration of NAPA and after treatment with NAPA. The initial dosage of NAPA was 500 mg every 8 hours, which was increased by 500 mg increments every few days until 90 percent suppression of arrhythmia or intolerable adverse effects occurred. Only two patients achieved 90 percent suppression of ventricular ectopic complexes. The mean plasma concentration associated with 90 percent suppression of arrhythmia in these two patients ws 12.6 and 32.3 mg/ml, respectively. One of these two patients was unable to continue long-term therapy with NAPA because of a rash. Other adverse effects included gastrointestinal symptoms in seven patients with visual symptoms in four patients at plasma concentratons as low as 6.9 mg/ml. NAPA obeyed linear pharmacokinetics over the range of dosages studied (500 to 2,500 mg every...Continue Reading
References
May 1, 1977·Circulation·A H GradmanD C Harrison
Dec 1, 1979·Circulation·P Jaillon, R A Winkle
May 1, 1979·Annals of Internal Medicine·G P StecJ Askenazi
Jun 1, 1978·Circulation·R A Winkle
Sep 1, 1978·Circulation·J MorganrothW B Dunkman
Sep 1, 1978·The American Journal of Cardiology·R A WinkleJ W Fitzgerald
Dec 1, 1976·Circulation·R A WinkleD C Harrison
Aug 11, 1975·Journal of Pharmacokinetics and Biopharmaceutics·J M StrongA J Atkinson
Jul 1, 1975·Indian Heart Journal·M KhalilullahS B Roy
Citations
Apr 1, 1989·Cardiovascular Drugs and Therapy·G K FeldB N Singh
Apr 1, 1982·American Heart Journal·R L WoosleyJ A Oates
Feb 1, 1985·American Heart Journal·D M Roden, R L Woosley
Apr 1, 1987·American Heart Journal·M A JosephsonB N Singh
Jan 1, 1986·Journal of the American College of Cardiology·V TorresJ C Somberg
Jun 1, 1987·Journal of the American College of Cardiology·K Okumura, A L Waldo
Nov 1, 1989·Medical Toxicology and Adverse Drug Experience·F A Fish, D M Roden
Dec 5, 1989·The American Journal of Cardiology·P Jaillon, M Drici
May 1, 1981·The American Journal of Cardiology·P JaillonR A Winkle
Sep 22, 1983·The American Journal of Cardiology·R E Kates
Nov 15, 1985·The American Journal of Cardiology·J WynnJ C Somberg
Aug 26, 1993·The American Journal of Cardiology·D M Roden
Jul 1, 1985·Pacing and Clinical Electrophysiology : PACE·W G Stevenson, J Weiss
Dec 1, 1982·The American Journal of Medicine·S C Vlay, P R Reid
Jan 1, 1984·Annals of the New York Academy of Sciences·E G Giardina
Jan 1, 1985·Pharmacotherapy·T M LuddenG T Kennedy
Apr 1, 1983·Drug Intelligence & Clinical Pharmacy·M B BottorffR L Batenhorst